Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 67

1.

Alcohol and fetoplacental vasoconstrictor reactivity.

Jakoubek V, Hampl V.

Physiol Res. 2018 Jul 17;67(3):509-513. Epub 2018 Mar 12.

2.

A Newly Identified Impurity in Polysorbate 80, the Long-Chain Ketone 12-Tricosanone, Forms Visible Particles in a Biopharmaceutical Drug Product.

Hampl V, Guo X, Ehrenstrasser C, Viertler M, Rayner L, Campanelli G, Schipflinger R, Thewes K, Cerreti A, Boehm S, Sonderegger C.

J Pharm Sci. 2018 Jun;107(6):1552-1561. doi: 10.1016/j.xphs.2018.02.017. Epub 2018 Feb 27.

PMID:
29499279
3.

Pregestational diabetes increases fetoplacental vascular resistance in rats.

Vajnerova O, Kafka P, Kratzerova T, Chalupsky K, Hampl V.

Placenta. 2018 Mar;63:32-38. doi: 10.1016/j.placenta.2018.01.008. Epub 2018 Jan 31.

PMID:
29486854
4.

Nitric oxide elevation in polytrauma is driven by oxygen radicals.

Beitl E, Baňasová A, Miková D, Hampl V.

Physiol Res. 2017 Dec 30;66(Supplementum 4):S561-S565.

5.

Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162].

Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, Daiber A.

Redox Biol. 2018 Apr;14:694-696. doi: 10.1016/j.redox.2017.10.001. Epub 2017 Oct 26. No abstract available.

6.

The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion.

Lamanna WC, Heller K, Schneider D, Guerrasio R, Hampl V, Fritsch C, Schiestl M.

J Oncol Pharm Pract. 2017 Jan 1:1078155217731506. doi: 10.1177/1078155217731506. [Epub ahead of print]

PMID:
28950806
7.

European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).

Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, Daiber A.

Redox Biol. 2017 Oct;13:94-162. doi: 10.1016/j.redox.2017.05.007. Epub 2017 May 18. Review. Erratum in: Redox Biol. 2018 Apr;14 :694-696.

8.

The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.

Hermanns C, Hampl V, Holzer K, Aigner A, Penkava J, Frank N, Martin DE, Maier KC, Waldburger N, Roessler S, Goppelt-Struebe M, Akrap I, Thavamani A, Singer S, Nordheim A, Gudermann T, Muehlich S.

Oncogene. 2017 Jun 15;36(24):3464-3476. doi: 10.1038/onc.2016.496. Epub 2017 Jan 23.

PMID:
28114277
9.

Chronic hypoxia increases fetoplacental vascular resistance in rat placenta perfused with blood.

Kafka P, Vajnerova O, Hampl V.

Bratisl Lek Listy. 2016;117(10):583-586.

PMID:
27826973
10.

Depletion of alveolar macrophages attenuates hypoxic pulmonary hypertension but not hypoxia-induced increase in serum concentration of MCP-1.

Žaloudíková M, Vytášek R, Vajnerová O, Hniličková O, Vízek M, Hampl V, Herget J.

Physiol Res. 2016 Nov 23;65(5):763-768. Epub 2016 Jul 15.

11.

Nitric oxide as an indicator for severity of injury in polytrauma.

Beitl E, Banasova A, Vlcek M, Mikova D, Hampl V.

Bratisl Lek Listy. 2016;117(4):217-20.

PMID:
27075385
12.

Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.

Hampl V, Herget J, Bíbová J, Baňasová A, Husková Z, Vaňourková Z, Jíchová Š, Kujal P, Vernerová Z, Sadowski J, Červenka L.

Physiol Res. 2015;64(1):25-38. Epub 2014 Sep 5.

13.
14.

Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence.

Hampl V, Martin C, Aigner A, Hoebel S, Singer S, Frank N, Sarikas A, Ebert O, Prywes R, Gudermann T, Muehlich S.

EMBO Mol Med. 2013 Sep;5(9):1367-82. doi: 10.1002/emmm.201202406. Epub 2013 Jul 29.

15.

Rho-kinase inhibition attenuates acute hypoxic fetoplacental vasoconstriction in the rat.

Kafka P, Vajnerová O, Herget J, Hampl V.

Physiol Res. 2012;61 Suppl 2:S43-8.

16.

Euglena gracilis and Trypanosomatids possess common patterns in predicted mitochondrial targeting presequences.

Krnáčová K, Vesteg M, Hampl V, Vlček Č, Horváth A.

J Mol Evol. 2012 Oct;75(3-4):119-29. doi: 10.1007/s00239-012-9523-2. Epub 2012 Oct 12.

PMID:
23064754
17.

The revised classification of eukaryotes.

Adl SM, Simpson AG, Lane CE, Lukeš J, Bass D, Bowser SS, Brown MW, Burki F, Dunthorn M, Hampl V, Heiss A, Hoppenrath M, Lara E, Le Gall L, Lynn DH, McManus H, Mitchell EA, Mozley-Stanridge SE, Parfrey LW, Pawlowski J, Rueckert S, Shadwick L, Schoch CL, Smirnov A, Spiegel FW.

J Eukaryot Microbiol. 2012 Sep;59(5):429-93. doi: 10.1111/j.1550-7408.2012.00644.x. Erratum in: J Eukaryot Microbiol. 2013 May-Jun;60(3):321. Shadwick, Lora [corrected to Shadwick, Laura].

18.

The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.

Muehlich S, Hampl V, Khalid S, Singer S, Frank N, Breuhahn K, Gudermann T, Prywes R.

Oncogene. 2012 Aug 30;31(35):3913-23. doi: 10.1038/onc.2011.560. Epub 2011 Dec 5.

PMID:
22139079
19.

New substituted isocoumarins and Dihydroisocoumarins and their cytotoxic activities.

Hampl V, Wetzel I, Bracher F, Krauss J.

Sci Pharm. 2011 Jan-Mar;79(1):21-30. doi: 10.3797/scipharm.1011-10. Epub 2010 Dec 18.

20.

Regulation of fetoplacental vascular bed by hypoxia.

Hampl V, Jakoubek V.

Physiol Res. 2009;58 Suppl 2:S87-93. Review.

21.

Hypercapnia attenuates hypoxic pulmonary hypertension by inhibiting lung radical injury.

Chovanec M, Novotná J, Wilhelm J, Hampl V, Vízek M, Herget J.

Physiol Res. 2009;58 Suppl 2:S79-85.

22.

Pre-arrest administration of the cell-permeable free radical scavenger tempol reduces warm ischemic damage of lung function in non-heart-beating donors.

Hodyc D, Hnilickova O, Hampl V, Herget J.

J Heart Lung Transplant. 2008 Aug;27(8):890-7. doi: 10.1016/j.healun.2008.05.019. Epub 2008 Jul 3.

PMID:
18656803
23.

Prevention of mast cell degranulation by disodium cromoglycate attenuates the development of hypoxic pulmonary hypertension in rats exposed to chronic hypoxia.

Banasová A, Maxová H, Hampl V, Vízek M, Povýsilová V, Novotná J, Vajnerová O, Hnilicková O, Herget J.

Respiration. 2008;76(1):102-7. doi: 10.1159/000121410. Epub 2008 Mar 18.

PMID:
18349522
24.

Chronic hypoxia increases fetoplacental vascular resistance and vasoconstrictor reactivity in the rat.

Jakoubek V, Bíbová J, Herget J, Hampl V.

Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1638-44. doi: 10.1152/ajpheart.01120.2007. Epub 2008 Feb 29.

25.

Selenium protects the immature rat heart against ischemia/reperfusion injury.

Ostadalova I, Vobecky M, Chvojkova Z, Mikova D, Hampl V, Wilhelm J, Ostadal B.

Mol Cell Biochem. 2007 Jun;300(1-2):259-67. Epub 2006 Dec 23.

PMID:
17187170
26.

Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in rats.

Vajner L, Vytásek R, Lachmanová V, Uhlík J, Konrádová V, Novotná J, Hampl V, Herget J.

Int J Exp Pathol. 2006 Oct;87(5):383-91.

27.

Voltage-gated calcium channels mediate hypoxic vasoconstriction in the human placenta.

Jakoubek V, Bíbová J, Hampl V.

Placenta. 2006 Sep-Oct;27(9-10):1030-3. Epub 2005 Dec 20.

PMID:
16368136
28.

Pulmonary vascular iNOS induction participates in the onset of chronic hypoxic pulmonary hypertension.

Hampl V, Bíbová J, Banasová A, Uhlík J, Miková D, Hnilicková O, Lachmanová V, Herget J.

Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L11-20. Epub 2005 Aug 19.

29.

N-acetylcysteine inhibits hypoxic pulmonary hypertension most effectively in the initial phase of chronic hypoxia.

Lachmanová V, Hnilicková O, Povýsilová V, Hampl V, Herget J.

Life Sci. 2005 May 27;77(2):175-82. Epub 2005 Feb 1.

PMID:
15862602
30.

Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats.

Hampl V, Bíbová J, Povýsilová V, Herget J.

Eur Respir J. 2003 May;21(5):862-5.

31.

Gender differences in the long-term effects of perinatal hypoxia on pulmonary circulation in rats.

Hampl V, Bibova J, Ostadalova I, Povysilova V, Herget J.

Am J Physiol Lung Cell Mol Physiol. 2003 Aug;285(2):L386-92. Epub 2003 Apr 11.

32.

Metalloproteinase inhibition by Batimastat attenuates pulmonary hypertension in chronically hypoxic rats.

Herget J, Novotna J, Bibova J, Povysilova V, Vankova M, Hampl V.

Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L199-208. Epub 2003 Mar 28.

33.

Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition.

Hampl V, Bíbová J, Stranák Z, Wu X, Michelakis ED, Hashimoto K, Archer SL.

Am J Physiol Heart Circ Physiol. 2002 Dec;283(6):H2440-9. Epub 2002 Aug 22.

34.

Diversity in mitochondrial function explains differences in vascular oxygen sensing.

Michelakis ED, Hampl V, Nsair A, Wu X, Harry G, Haromy A, Gurtu R, Archer SL.

Circ Res. 2002 Jun 28;90(12):1307-15.

PMID:
12089069
35.

Hyperoxia and recovery from hypoxia alter collagen in peripheral pulmonary arteries similarly.

Novotná J, Bíbová J, Hampl V, Deyl Z, Herget J.

Physiol Res. 2001;50(2):153-63.

36.

Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5.

Archer SL, London B, Hampl V, Wu X, Nsair A, Puttagunta L, Hashimoto K, Waite RE, Michelakis ED.

FASEB J. 2001 Aug;15(10):1801-3. No abstract available.

PMID:
11481235
37.

Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels.

Belohlávková S, Simák J, Kokesová A, Hnilicková O, Hampl V.

J Appl Physiol (1985). 2001 Aug;91(2):755-61.

39.

Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension.

Hampl V, Herget J.

Physiol Rev. 2000 Oct;80(4):1337-72. Review.

40.

[Nitric oxide and regulation of pulmonary vessels].

Hampl V.

Cesk Fysiol. 2000 Feb;49(1):22-9. Review. Czech.

PMID:
10953503
41.

[Anorectics and pulmonary hypertension].

Bíbová J, Hampl V.

Cas Lek Cesk. 2000 Feb 16;139(3):67-70. Czech.

PMID:
10838744
42.
43.

Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes.

Archer SL, Souil E, Dinh-Xuan AT, Schremmer B, Mercier JC, El Yaagoubi A, Nguyen-Huu L, Reeve HL, Hampl V.

J Clin Invest. 1998 Jun 1;101(11):2319-30.

44.

Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction.

Weir EK, Reeve HL, Huang JM, Michelakis E, Nelson DP, Hampl V, Archer SL.

Circulation. 1996 Nov 1;94(9):2216-20.

PMID:
8901674
45.

Origins of breath nitric oxide in humans.

Dillon WC, Hampl V, Shultz PJ, Rubins JB, Archer SL.

Chest. 1996 Oct;110(4):930-8.

PMID:
8874248
46.

The somatostatin analog angiopeptin does not reduce chronic hypoxic pulmonary hypertension in rats.

Sidney EJ, Hampl V, Nelson DP, Archer SL, Foegh ML, Cathapermal SS, Weir EK.

Proc Soc Exp Biol Med. 1996 Oct;213(1):43-9.

PMID:
8820822
47.

Chronic infusion of nitric oxide in experimental pulmonary hypertension: pulmonary pressure-flow analysis.

Hampl V, Tristani-Firouzi M, Nelson DP, Archer SL.

Eur Respir J. 1996 Jul;9(7):1475-81.

48.

Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia.

Archer SL, Huang JM, Reeve HL, Hampl V, Tolarová S, Michelakis E, Weir EK.

Circ Res. 1996 Mar;78(3):431-42.

PMID:
8593702
49.

Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension.

Hampl V, Tristani-Firouzi M, Hutsell TC, Archer SL.

Cardiovasc Res. 1996 Jan;31(1):55-62.

PMID:
8849589
50.

Dithionite increases radical formation and decreases vasoconstriction in the lung. Evidence that dithionite does not mimic alveolar hypoxia.

Archer SL, Hampl V, Nelson DP, Sidney E, Peterson DA, Weir EK.

Circ Res. 1995 Jul;77(1):174-81.

PMID:
7788875
51.
52.

Nitric oxide in the pulmonary circulation during hypoxia.

Hampl V.

Anaesthesia. 1995 Mar;50(3):264-5. No abstract available.

53.

Long-term effects of prenatal indomethacin administration on the pulmonary circulation in rats.

Herget J, Hampl V, Povýsilová V, Slavík Z.

Eur Respir J. 1995 Feb;8(2):209-15.

54.
55.

Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.

Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK.

Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7583-7.

56.

Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats.

Isaacson TC, Hampl V, Weir EK, Nelson DP, Archer SL.

J Appl Physiol (1985). 1994 Feb;76(2):933-40.

PMID:
7513687
57.

Chronic hypoxic pulmonary hypertension. Is thrombin involved?

Hampl V, Archer SL, Bach R, Nelson DP, Weir EK.

Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):1043-8.

PMID:
8214923
58.

Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure.

Hampl V, Archer SL, Nelson DP, Weir EK.

J Appl Physiol (1985). 1993 Oct;75(4):1748-57.

PMID:
7506706
59.

NG-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise.

Archer SL, Hampl V.

Biochem Biophys Res Commun. 1992 Oct 30;188(2):590-6.

PMID:
1445303
60.
61.
62.

[Tissue factors involved in hypoxic pulmonary vasoconstriction].

Hampl V, Herget J.

Cesk Fysiol. 1991;40(1):1-23. Review. Czech. No abstract available.

PMID:
2025907
63.

[Hypoxic pulmonary hypertension].

Hampl V.

Cesk Fysiol. 1991;40(3):255-71. Review. Czech. No abstract available.

PMID:
1893418
64.

Possible mechanisms of oxygen sensing in the pulmonary circulation.

Hampl V, Herget J.

Physiol Res. 1991;40(5):463-70. Review.

PMID:
1812974
65.
66.
67.

[Reactivity of the pulmonary vessels in hypoxic pulmonary hypertension].

Hampl V, Herget J.

Cesk Fysiol. 1988;37(3):193-209. Review. Czech. No abstract available.

PMID:
3044625

Supplemental Content

Loading ...
Support Center